Strengthening sales efforts to prescribing physicians through the Neo-Primary Strategy
First written in FY2026-H1. 1 of 2 entries say "Advanced", first in FY2026. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「As part of its efforts to maximize the capabilities of its MSs, the Company is implementing the Neo-Primary Strategy with the industry's largest number of MSs and pursuing an aggressive sales expansion while improving operations through the use of product services, thereby focusing particularly on sales activities targeting prescribing physicians and achieving high sales growth through its clinic channel.」
The Company disclosed that it achieved high sales growth through its clinic channel under the Neo-Primary Strategy by combining the industry's largest number of MSs, the use of product services, and sales efforts targeting prescribing physicians. - FY2026-H1First statedAnnual report
「By pursuing a neo-primary strategy with the industry's leading number of MS personnel, improving operations through the use of product services and actively developing sales activities, the company has focused particularly on sales to prescribing physicians and achieved strong sales growth through its clinic channel.」
The Company disclosed for the first time its strategy of strengthening sales efforts to prescribing physicians and clinics by positioning specialty pharmaceuticals and other products as products that can also be prescribed in the primary care field, and leveraging its industry-leading number of MSs and product services.